Harvey Sandler Revocable Trust 4
4 · bioAffinity Technologies, Inc. · Filed Jul 2, 2024
Insider Transaction Report
Form 4
Rubin Gary D
Director10% Owner
Transactions
- Award
Common Stock
2024-07-01+33,784→ 146,597 total
Holdings
- 1,584,144(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Grant of restricted shares of common stock, par value $0.007 per share, that vest pro rata on a monthly basis for 12 months commencing on August 1, 2024.
- [F2]Represents shares of common stock owned directly by the Harvey Sandler Revocable Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. Rubin, as co-trustee of the Trust. Mr. Rubin disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.